| 标题 |
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medicinal Chemistry 作者:Huikai Sun; Holger Monenschein; Hans H. Schiffer; H Reichard; Shota Kikuchi; et al 出版日期:2021-04-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)